News
MIST
2.200
+8.37%
0.170
Weekly Report: what happened at MIST last week (0406-0410)?
Weekly Report · 2d ago
Milestone Pharmaceuticals Launches RESET-PSVT Registry To Build Real-World Evidence For CARDAMYST
NASDAQ · 5d ago
Milestone Pharmaceuticals provides details on RESET-PSVT trial
TipRanks · 5d ago
Milestone launches Phase 4 RESET-PSVT registry for CARDAMYST nasal spray in adults
Reuters · 5d ago
MILESTONE PHARMACEUTICALS ANNOUNCES RESET-PSVT REGISTRY TO GENERATE REAL-WORLD EVIDENCE ON CARDAMYST™ (ETRIPAMIL) NASAL SPRAY IN PATIENTS WITH PSVT
Reuters · 5d ago
MILESTONE PHARMACEUTICALS INC <MIST.O>: RAYMOND JAMES INITIATES COVERAGE WITH STRONG BUY RATING; TARGET PRICE $6
Reuters · 5d ago
Milestone Pharmaceuticals initiated with a Strong Buy at Raymond James
TipRanks · 5d ago
Milestone Pharma to Present at Needham Virtual Healthcare Conference
Reuters · 04/07 12:41
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Barchart · 04/07 07:30
Weekly Report: what happened at MIST last week (0330-0403)?
Weekly Report · 04/06 09:14
Milestone Pharmaceuticals grants 123,000 inducement stock options to new hires
Reuters · 04/02 12:02
MILESTONE PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 04/02 12:00
Milestone says Express Scripts adds CARDAMYST to commercial national formularies
Reuters · 03/31 22:18
Milestone Pharmaceuticals Stock Up As CARDAMYST Added To Express Scripts Formularies
NASDAQ · 03/31 13:58
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)
TipRanks · 03/31 13:50
Milestone Pharmaceuticals announces availability of Cardamyst on Express Scripts
TipRanks · 03/31 12:09
Weekly Report: what happened at MIST last week (0323-0327)?
Weekly Report · 03/30 09:14
Analysts Offer Insights on Healthcare Companies: Rubicon Organics (OtherROMJF), Alcon (ALC) and Milestone Pharmaceuticals (MIST)
TipRanks · 03/25 13:40
Milestone Pharmaceuticals files Form 3 for GC and Chief Compliance Officer David I. Sandoval
Reuters · 03/23 22:52
More
Webull provides a variety of real-time MIST stock news. You can receive the latest news about Milestone Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About MIST
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.